Scrip RSS Feedhttps://insights.citeline.comThe Latest News & Analysis from ScripTue, 12 May 2026 15:23:24 +0000en1hourly1 https://insights.citeline.com/scrip/podcasts/scrip-awards-podcast-call-for-entries-2026-new-ai-category-triana-interview-ARY7RAJBZ5BWNCMYH4AKSU3BYI/<![CDATA[Scrip Awards Podcast: Call For Entries 2026, New AI Category, Triana Interview]]>premium

      
]]> https://feeds.feedblitz.com/~/955802489/0/scrip~Scrip-Awards-Podcast-Call-For-Entries-New-AI-Category-Triana-Interview/https://insights.citeline.com/scrip/podcasts/scrip-awards-podcast-call-for-entries-2026-new-ai-category-triana-interview-ARY7RAJBZ5BWNCMYH4AKSU3BYI/
      
]]> Tue, 12 May 2026 15:13:11 +0000 https://insights.citeline.com/scrip/business/earnings/bayer-back-in-the-market-for-bolt-ons-BLDO3UD2BBB5ZFJR335RYWXHO4/<![CDATA[Bayer Back In The Market For Bolt-Ons]]>premium

      
]]> https://feeds.feedblitz.com/~/955800428/0/scrip~Bayer-Back-In-The-Market-For-BoltOns/https://insights.citeline.com/scrip/business/earnings/bayer-back-in-the-market-for-bolt-ons-BLDO3UD2BBB5ZFJR335RYWXHO4/
      
]]> Tue, 12 May 2026 14:25:37 +0000 https://insights.citeline.com/scrip/business/stock-watch/stock-watch-us-pharma-rescues-earnings-season-as-lilly-abbvie-and-bms-beat-JRAU36NAJBBCZOJEP2UYPSMTMM/<![CDATA[Stock Watch: US Pharma Rescues Earnings Season As Lilly, AbbVie And BMS Beat]]>premium

      
]]> https://feeds.feedblitz.com/~/955789295/0/scrip~Stock-Watch-US-Pharma-Rescues-Earnings-Season-As-Lilly-AbbVie-And-BMS-Beat/https://insights.citeline.com/scrip/business/stock-watch/stock-watch-us-pharma-rescues-earnings-season-as-lilly-abbvie-and-bms-beat-JRAU36NAJBBCZOJEP2UYPSMTMM/
      
]]> Tue, 12 May 2026 10:30:00 +0000 https://insights.citeline.com/scrip/focus-on-asia/bridging-the-reimbursement-and-screening-gap-astrazenecas-asia-strategy-YKJE5P6XNRGKPA7YICMACNG3II/<![CDATA[Bridging The Reimbursement And Screening Gap: AstraZeneca’s Asia Strategy]]>premium

      
]]> https://feeds.feedblitz.com/~/955785206/0/scrip~Bridging-The-Reimbursement-And-Screening-Gap-AstraZeneca%e2%80%99s-Asia-Strategy/https://insights.citeline.com/scrip/focus-on-asia/bridging-the-reimbursement-and-screening-gap-astrazenecas-asia-strategy-YKJE5P6XNRGKPA7YICMACNG3II/
      
]]> Tue, 12 May 2026 08:56:44 +0000 https://insights.citeline.com/scrip/business/deals/hengrui-bms-strike-huge-152bn-alliance-for-bundle-of-preclinical-assets-4HE3IXJWOZC4LJQLM2QMHFGZCQ/<![CDATA[Hengrui, BMS Strike Huge $15.2bn Alliance For Bundle Of Preclinical Assets]]>premium

      
]]> https://feeds.feedblitz.com/~/955785203/0/scrip~Hengrui-BMS-Strike-Huge-bn-Alliance-For-Bundle-Of-Preclinical-Assets/https://insights.citeline.com/scrip/business/deals/hengrui-bms-strike-huge-152bn-alliance-for-bundle-of-preclinical-assets-4HE3IXJWOZC4LJQLM2QMHFGZCQ/
      
]]> Tue, 12 May 2026 09:01:49 +0000 https://insights.citeline.com/scrip/r-and-d/clinical-trials/hengruibravehearts-myosin-inhibitor-shows-nhcm-disease-modifying-signal-5MY7MZW5U5AKPFWWINRSFLGGNQ/<![CDATA[Hengrui/Braveheart’s Myosin Inhibitor Shows nHCM Disease-Modifying Signal]]>premium

      
]]> https://feeds.feedblitz.com/~/955784303/0/scrip~HengruiBraveheart%e2%80%99s-Myosin-Inhibitor-Shows-nHCM-DiseaseModifying-Signal/https://insights.citeline.com/scrip/r-and-d/clinical-trials/hengruibravehearts-myosin-inhibitor-shows-nhcm-disease-modifying-signal-5MY7MZW5U5AKPFWWINRSFLGGNQ/
      
]]> Tue, 12 May 2026 08:23:58 +0000 https://insights.citeline.com/scrip/business/earnings/mounjaro-boosts-lillys-japan-sales-but-price-cut-concerns-linger-WWFOC3J5S5ESTMCULAV2SXNK3U/<![CDATA[Mounjaro Boosts Lilly’s Japan Sales But Price Cut Concerns Linger]]>premium

      
]]> https://feeds.feedblitz.com/~/955783148/0/scrip~Mounjaro-Boosts-Lilly%e2%80%99s-Japan-Sales-But-Price-Cut-Concerns-Linger/https://insights.citeline.com/scrip/business/earnings/mounjaro-boosts-lillys-japan-sales-but-price-cut-concerns-linger-WWFOC3J5S5ESTMCULAV2SXNK3U/
      
]]> Tue, 12 May 2026 07:57:16 +0000 https://insights.citeline.com/scrip/business/deals/gifrer-acquisition-to-boost-celltrions-french-reach-portfolio-VFC7YE2TPRA63A7BIV6XH3CJ5Q/<![CDATA[Gifrer Acquisition To Boost Celltrion’s French Reach, Portfolio ]]>premium

      
]]> https://feeds.feedblitz.com/~/955772702/0/scrip~Gifrer-Acquisition-To-Boost-Celltrion%e2%80%99s-French-Reach-Portfolio/https://insights.citeline.com/scrip/business/deals/gifrer-acquisition-to-boost-celltrions-french-reach-portfolio-VFC7YE2TPRA63A7BIV6XH3CJ5Q/
      
]]> Tue, 12 May 2026 02:26:47 +0000 https://insights.citeline.com/scrip/r-and-d/pipeline-watch/pipeline-watch-six-approvals-and-three-phase-iii-readouts-7LYOGEUT4FFCLHJ3QHAKYSI4AY/<![CDATA[Pipeline Watch: Six Approvals And Three Phase III Readouts ]]>premium

      
]]> https://feeds.feedblitz.com/~/955747250/0/scrip~Pipeline-Watch-Six-Approvals-And-Three-Phase-III-Readouts/https://insights.citeline.com/scrip/r-and-d/pipeline-watch/pipeline-watch-six-approvals-and-three-phase-iii-readouts-7LYOGEUT4FFCLHJ3QHAKYSI4AY/
      
]]> Mon, 11 May 2026 15:03:56 +0000 https://insights.citeline.com/scrip/r-and-d/clinical-trials/novos-microrna-therapy-disappoints-in-post-heart-attack-patients-43OXX5GQGJHYFISIMGQMHGOS3I/<![CDATA[Novo’s MicroRNA Therapy Disappoints In Post-Heart Attack Patients]]>premium

      
]]> https://feeds.feedblitz.com/~/955738133/0/scrip~Novo%e2%80%99s-MicroRNA-Therapy-Disappoints-In-PostHeart-Attack-Patients/https://insights.citeline.com/scrip/r-and-d/clinical-trials/novos-microrna-therapy-disappoints-in-post-heart-attack-patients-43OXX5GQGJHYFISIMGQMHGOS3I/
      
]]> Mon, 11 May 2026 11:52:12 +0000 https://insights.citeline.com/scrip/business/earnings/almirall-hails-ebglyss-growth-and-pipeline-advances-7ELTJMMCZNE2RKCYXH5H3FH26E/<![CDATA[Almirall Hails Ebglyss Growth And Pipeline Advances]]>premium

      
]]> https://feeds.feedblitz.com/~/955750421/0/scrip~Almirall-Hails-Ebglyss-Growth-And-Pipeline-Advances/https://insights.citeline.com/scrip/business/earnings/almirall-hails-ebglyss-growth-and-pipeline-advances-7ELTJMMCZNE2RKCYXH5H3FH26E/
      
]]> Mon, 11 May 2026 16:05:00 +0000 https://insights.citeline.com/scrip/therapeutic-category/respiratory/liquidia-and-united-duke-it-out-in-treprostinil-market-ZDWJEFZ6KZFVFGPYAUZZIUNWJ4/<![CDATA[Liquidia And United Duke It Out In Treprostinil Market ]]>premium

      
]]> https://feeds.feedblitz.com/~/955760993/0/scrip~Liquidia-And-United-Duke-It-Out-In-Treprostinil-Market/https://insights.citeline.com/scrip/therapeutic-category/respiratory/liquidia-and-united-duke-it-out-in-treprostinil-market-ZDWJEFZ6KZFVFGPYAUZZIUNWJ4/
      
]]> Mon, 11 May 2026 20:26:41 +0000 https://insights.citeline.com/scrip/advanced-therapies/cell-therapies/novo-nordisk-hands-parkinsons-cell-therapy-to-cellular-intelligence-AUF6WRKTYVEWDJQKHXCLUP4SLM/<![CDATA[Novo Nordisk Hands Parkinson’s Cell Therapy To Cellular Intelligence]]>premium

      
]]> https://feeds.feedblitz.com/~/955762397/0/scrip~Novo-Nordisk-Hands-Parkinson%e2%80%99s-Cell-Therapy-To-Cellular-Intelligence/https://insights.citeline.com/scrip/advanced-therapies/cell-therapies/novo-nordisk-hands-parkinsons-cell-therapy-to-cellular-intelligence-AUF6WRKTYVEWDJQKHXCLUP4SLM/
      
]]> Mon, 11 May 2026 21:00:58 +0000 https://insights.citeline.com/scrip/business/earnings/daiichi-sankyos-oncology-strategy-5-years-5-drugs-top-5-cancer-companies-XOHBSYKGW5BLLARIO7QNOKE3JA/<![CDATA[Daiichi Sankyo’s Oncology Strategy: 5 Years, 5 Drugs, Top 5 Cancer Companies]]>premium

      
]]> https://feeds.feedblitz.com/~/955762394/0/scrip~Daiichi-Sankyo%e2%80%99s-Oncology-Strategy-Years-Drugs-Top-Cancer-Companies/https://insights.citeline.com/scrip/business/earnings/daiichi-sankyos-oncology-strategy-5-years-5-drugs-top-5-cancer-companies-XOHBSYKGW5BLLARIO7QNOKE3JA/
      
]]> Mon, 11 May 2026 21:09:23 +0000Alaric DeArment https://insights.citeline.com/scrip/drug-pricing/lib-launches-lerochol-at-lower-direct-to-patient-cost-than-other-pcsk9-drugs-A5HULFJK6VD2XDHJIJE2YCIWGM/<![CDATA[LIB Launches Lerochol At Lower Direct-To-Patient Cost Than Other PCSK9 Drugs]]>premium

      
]]> https://feeds.feedblitz.com/~/955765280/0/scrip~LIB-Launches-Lerochol-At-Lower-DirectToPatient-Cost-Than-Other-PCSK-Drugs/https://insights.citeline.com/scrip/drug-pricing/lib-launches-lerochol-at-lower-direct-to-patient-cost-than-other-pcsk9-drugs-A5HULFJK6VD2XDHJIJE2YCIWGM/
      
]]> Mon, 11 May 2026 22:47:10 +0000 https://insights.citeline.com/scrip/business/deals/curacle-inks-1bn-bispecific-antibody-deal-with-memento-5EBM3MSWNFBHTGSST4RVUHZXKQ/<![CDATA[Curacle Inks $1bn Bispecific Deal With Memento]]>premium

      
]]> https://feeds.feedblitz.com/~/955720808/0/scrip~Curacle-Inks-bn-Bispecific-Deal-With-Memento/https://insights.citeline.com/scrip/business/deals/curacle-inks-1bn-bispecific-antibody-deal-with-memento-5EBM3MSWNFBHTGSST4RVUHZXKQ/
      
]]> Mon, 11 May 2026 04:53:36 +0000 https://insights.citeline.com/scrip/business/earnings/korea-q1-roundup-hanmi-gears-for-obesity-launch-strong-growth-for-sk-biopharm-KYTGHV35HRGAJNGYDGMRVCXOIE/<![CDATA[Korea Q1 Roundup: Hanmi Gears For Obesity Launch, Strong Growth For SK Biopharm ]]>premium

      
]]> https://feeds.feedblitz.com/~/955722167/0/scrip~Korea-Q-Roundup-Hanmi-Gears-For-Obesity-Launch-Strong-Growth-For-SK-Biopharm/https://insights.citeline.com/scrip/business/earnings/korea-q1-roundup-hanmi-gears-for-obesity-launch-strong-growth-for-sk-biopharm-KYTGHV35HRGAJNGYDGMRVCXOIE/
      
]]> Mon, 11 May 2026 05:46:49 +0000 https://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/quick-listen-scrips-five-must-know-things-IEFP6L4BNNCFTNMAXVIX54E6CQ/<![CDATA[Quick Listen: Scrip’s Five Must-Know Things]]>free

      
]]> https://feeds.feedblitz.com/~/955715924/0/scrip~Quick-Listen-Scrip%e2%80%99s-Five-MustKnow-Things/https://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/quick-listen-scrips-five-must-know-things-IEFP6L4BNNCFTNMAXVIX54E6CQ/
      
]]> Mon, 11 May 2026 02:53:23 +0000